FGFR2 and craniosynostosis: The most important impact for genetic counseling in families with a history of affected AS patients is the noninvasive cell-free fetal DNA present in the maternal blood or using an amniotic fluid sample to assess for known pathogenic FGFR2 gene variants in the first trimester in families with high-risk family histories of craniosynostosis.